Eledon Pharmaceuticals ELDN
NASDAQ ELDN
$3.02 +0.09 (+3.07%)
As of: Sep 4, 2026 · 3:59 PM EDT

Eledon Pharmaceuticals (ELDN) Market Capitalization (2014 - 2026)

Analysis

Eledon Pharmaceuticals (ELDN) Market Capitalization (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Eledon Pharmaceuticals 344.87 Mn 344.87 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 447.71 Mn
Mar 31, 2026 346.27 Mn
Dec 31, 2025 113.90 Mn
Sep 30, 2025 199.83 Mn
Jun 30, 2025 209.09 Mn
Mar 31, 2025 261.46 Mn
Dec 31, 2024 200.47 Mn
Sep 30, 2024 161.68 Mn
Jun 30, 2024 127.07 Mn
Mar 31, 2024 63.89 Mn
Dec 31, 2023 54.48 Mn
Sep 30, 2023 51.33 Mn
Jun 30, 2023 39.46 Mn
Mar 31, 2023 58.43 Mn
Dec 31, 2022 56.45 Mn
Sep 30, 2022 68.33 Mn
Jun 30, 2022 60.41 Mn
Mar 31, 2022 67.75 Mn
Dec 31, 2021 78.87 Mn
Sep 30, 2021 110.52 Mn